Good news: mild cases of Covid-19 give long-lasting antibodies, possibly for life
New research provides high hopes for those mildly ill with Covid-19. Antibodies produced by ...
Read moreNew research provides high hopes for those mildly ill with Covid-19. Antibodies produced by ...
Read more100% effectiveness and a booster every 3 years: the second Russian vaccine, EpiVacCorona, could mark a step forward ...
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
© 2023 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.